|
Volumn 174, Issue 5, 2005, Pages 2065-2066
|
Uro-science
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACYLTRANSFERASE;
BIOLOGICAL MARKER;
TUMOR MARKER;
ACCURACY;
BLADDER CANCER;
CANCER RISK;
CELL CULTURE;
CHROMOSOME BREAKAGE;
CHROMOSOME LOSS;
CYTOGENETICS;
DNA POLYMORPHISM;
FLUORESCENCE IN SITU HYBRIDIZATION;
FOLLOW UP;
FUSION GENE;
GENETIC ANALYSIS;
HUMAN;
KARYOTYPE;
MUTATION;
NOTE;
PRIORITY JOURNAL;
RISK ASSESSMENT;
TRANSITIONAL CELL CARCINOMA;
UROTHELIUM;
ARTICLE;
BLADDER TUMOR;
CASE CONTROL STUDY;
CHROMOSOME ABERRATION;
COMPARATIVE STUDY;
CYTOLOGY;
FEMALE;
GENETIC PREDISPOSITION;
GENETICS;
IN VITRO STUDY;
KARYOTYPING;
MALE;
PATHOLOGY;
SENSITIVITY AND SPECIFICITY;
TUMOR CELL LINE;
CANCER STAGING;
CYSTOSCOPY;
IMMUNOHISTOCHEMISTRY;
MORTALITY;
NEEDLE BIOPSY;
PROGNOSIS;
REVIEW;
SURVIVAL;
URINE;
CARCINOMA, TRANSITIONAL CELL;
CASE-CONTROL STUDIES;
CELL LINE, TUMOR;
CHROMOSOME ABERRATIONS;
CYTOGENETICS;
FEMALE;
GENETIC PREDISPOSITION TO DISEASE;
HUMANS;
IN SITU HYBRIDIZATION, FLUORESCENCE;
KARYOTYPING;
MALE;
SENSITIVITY AND SPECIFICITY;
URINARY BLADDER NEOPLASMS;
UROTHELIUM;
BIOPSY, NEEDLE;
CYSTOSCOPY;
IMMUNOHISTOCHEMISTRY;
NEOPLASM STAGING;
PROGNOSIS;
SURVIVAL ANALYSIS;
TUMOR MARKERS, BIOLOGICAL;
|
EID: 27544470303
PISSN: 00225347
EISSN: None
Source Type: Journal
DOI: 10.1097/01.ju.0000183078.11059.00 Document Type: Article |
Times cited : (7)
|
References (0)
|